Durham, NC, United States of America

MacDonald Isere

This inventor holds 1 USPTO granted patent. Top assignee: Kyndryl, Inc.. Active years: 2022.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: MacDonald Isere: Innovator in Computer Vision Syndrome Prevention

Introduction

MacDonald Isere is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of artificial intelligence, particularly in the prevention of computer vision syndrome (CVS). His innovative approach utilizes explainable artificial intelligence to address a growing concern in today's digital age.

Latest Patents

MacDonald Isere holds a patent for the "Prevention of computer vision syndrome using explainable artificial intelligence." This technology applies explainable artificial training algorithms (XAI) to train machine learning algorithms. The goal is to identify potentially developing CVS and recommend remedial actions that users can take to counteract the condition. The XAI includes a Contrastive Explainability model, which enhances the understanding of how various input parameters, such as blink rate, correlate with the development of CVS in users.

Career Highlights

MacDonald Isere is currently employed at Kyndryl, Inc., where he continues to innovate and develop solutions in the realm of artificial intelligence. His work focuses on creating technologies that improve user experience and health in relation to prolonged computer use.

Collaborations

He collaborates with talented individuals such as William G Dusch and Nicholas L Graham, contributing to a dynamic work environment that fosters innovation and creativity.

Conclusion

MacDonald Isere's work in the field of artificial intelligence and his patent for preventing computer vision syndrome highlight his commitment to improving user health in a technology-driven world. His contributions are paving the way for future advancements in this critical area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…